1,5-Anhydro-D-fructose (1,5-AF) is a monosaccharide that shares a structural similarity to glucose. 1,5-AF is found in fungi, algae, Escherichia coli and rat liver and is produced by the degradation of starch and glycogen, which is catalyzed by the enzyme α-1,4-glucan lyase. However, the physiological role of 1,5-AF in mammalian tissues is not well understood. Here, we investigated the anti-obesity potential of 1,5-AF on adipogenesis in 3T3-L1 adipocytes. 1,5-AF caused a significant decrease in GPDH activity in 3T3-L1 preadipocytes and mature adipocytes without eliciting cytotoxicity, and inhibited cellular lipid accumulation through down-regulation of transcription factors such as PPARγ and C/EBPα. 1,5-AF also induced dose-dependent phosphorylation of AMP-activated protein kinase (AMPK), a cellular energy sensor. However, the total AMPK protein content remained unchanged. Furthermore, 1,5-AF increased the levels of reactive oxygen species, an important upstream signal for AMPK activation in 3T3-L1 adipocytes. Our results show that 1,5-AF exerts anti-obesity action in vitro and suggest that 1,5-AF is potentially a novel preventative agent for obesity and other metabolic diseases.
HammJK, ParkBH, FarmerSR. (2001) A role for C/EBP beta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1preadipocytes. Journal of Biological Chemistry, 276, 18464–18471.
5.
El-JackAK, HammJK, PilchPF, FarmerSR. (1999) Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPAR gamma and C/EBP alpha. Journal of Biological Chemistry, 274, 7946–7951.
6.
CarlingD. (2004) The AMP-activated protein kinase cascade-a unifying system for energy control. Trends in Biochemical Sciences, 29, 18–24.
7.
HardieDG, HawleySA, ScottJW. (2006) AMP-activated protein kinase-developing of the energy sensor concept. Journal of Physiology-London, 574, 7–15.
8.
DagonY, AvrahamY, BerryEM. (2006) AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2α in adipocytes. Biochemical Biophysical Research Communications, 340, 43–47.
9.
GiriS, RattanR, HaqE, KhanM, YasminR, WonJ-S, KeyL, SinghAK, SinghI. (2006) AICAR inhibits adipocyte differentiation in 3T3-L1 and restores metabolic alterations in diet-induced obesity mice model. Nutrition & Metabolism, 3, 31.
10.
YuS. (2008) The anhydrofructose pathway. IUBMB Life, 60, 798–809.
11.
BauteMA, DeffieuxG, BauteR. (1986) Bioconvension of carbohydrates to unusual pyrone compounds in fungi: Occurrence of microthcin in morels. Phytochemistry, 25, 1472–1473.
12.
DeffieuxG, BauteR, BauteMA, AtfaniM, CarpyA. (1987) 1.5-Anhydro-D-fructose, the precursor of pyrone microthecin in Morchella vulgaris. Phytochemistry, 26, 1391–1393.
13.
NakamuraT, NaitoA, TakahashiY, AkanumaH. (1986) Oxidation of 1,5-anhydro-D-glucitol to 1.5,-anhydro-D-fructose catalyzed by an enzyme from bacterial-membranes. Journal of Biochemistry, 99, 607–613
14.
ShigaY, KametaniT, KadokuraT, AkanumaH. (1999) 1,5-Anhydroglucitol promotes glycogenolysis in Eschericia coli. Journal of Biochemistry, 125, 166–172.
15.
KametaniS, ShigaY, AkanumaH. (1996) Hepatic production of 1,5-anhydrofructose and 1,5-anhydroglucitol in rat by the third glycogenolytic pathway. European Journal of Biochemistry, 242, 832–838.
16.
YamajiK, SarkerKP, MaruyamaI, HizukuriS. (2002) Antioxidant effects of 1,5-anhydro-D-fructose, a new natural sugar, in vitro. Planta Medica, 68, 16–19.
17.
YuS, FiskesundR. (2006) The anhydrofructose pathway and its possible role in stress response and signaling. Biochimica et Biophysica Acta, 1760, 1314–1322.
18.
AhrenB, HolstJJ, YuS. (2000) 1,5-Anhydro-D-fructose increases glucose tolerance by increasing glucagon peptide-1 and insulin in mice. European Journal of Pharmacology, 397, 219–225.
19.
MeiJ, YuS, AhrenB. (2010) Study on administration of 1,5-anhydro-D-fructose in C57BL/6J mice challenged with high-fat diet. BMC Endocrine Disorders, 10, 17–21.
20.
HwangJT, LeeM, JungSN, LeeHJ, KangI, KimSS, HaJ. (2004) AMP-activated proteinkinase activity is required for vanadate-induced hypoxia-inducible factor 1alpha expression in DU145 cells. Carcinogenesis, 25, 2497–2507.
21.
SmithJ, Al-AmriM, DorairajP, SnidermanA. (2006) The adipocyte life cycle hypothesis. Clinical Science, 110, 1–9.
SpiegelmanBM, FlierJS. (2001) Obesity and the regulation of energy balance. Cell, 104, 531–543.
26.
WinderWW, HolmesBF, RubinkDS, JensenEB, ChenM, HolloszyJO. (2000) Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. Journal of Applied Physiology, 88, 2219–2226.
27.
BrusqJM, AncellinN, GrondinP, GuillardR, MartinS, SaintillanY, IssandouM. (2006) Inhibition of lipid synthesis through activation of AMPK kinase: an additional mechanism for the hypolipidemic effects of berberine. Journal of Lipid Research, 47, 1281–1288.
28.
HwangJT, ParkIJ, ShinJI, LeeYK, LeeSK, BaikHW, HaJ, ParkOJ. (2005) Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochemical Biophysical Research Communications, 338, 694–699.
29.
HuangB, YuanHD, KinDY, QuanHY, ChungSH. (2011) Cinnamaldehyde prevents adipocyte differentiation and adipogenesis via regulation of peroxisome proliferator-activated receptor-gamma (PPAR gamma) and AMP-activated protein kinase (AMPK) pathways. Journal of Agricultural and Food Chemistry, 59, 3666–3673.
30.
GaoY, ZhouY, XuAM, WuDG. (2008) Effect of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cell. Biological & Pharmaceutical Bulletin, 31, 1716–1722.
31.
ChobotV, HadacekF. (2011) Exploration of pro-oxidant and antioxidant activities of the flavonoid myricetin. Redox Report: Communications in Free Radical Research, 16, 242–247.
32.
YinJJ, FuPP, LutterodtH, ZhouYT, AntholineWE, WamerW. (2012) Dual role of selected antioxidants found in dietary supplements: crossover between anti- and pro-oxidant activities in the presence of copper. Journal of Agricultural and Food Chemistry, 60, 2554–2561.
33.
RiddellRJ, ClothierRH, BallsM. (1986) An evaluation of three in vitro cytotoxicity assays. Food and Chemical Toxicology, 24, 469–471.
34.
FotakisG, TimbrellJA. (2006) In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicology Letters, 160, 171–177.
35.
KubotaH, MoriiR, Kojima-YuasaA, HuangX, YanoY, Matsui-YuasaI. (2009) Effect of Zizphus jujuba extract on the inhibition of adipogenesis in 3T3-L1 preadipocytes. The American Journal of Chinese Medicine, 37, 597–608.
36.
RamirezzacariasJL, CastromunozledoF, KuriharcuchW. (1992) Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red-O. Histochemistry, 97, 493–497.
37.
WiseLS, GreenH. (1979) Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. Journal of Biological Chemistry, 254, 273–275.
